We are live on
!
Find out more
Allspring Global Investments Portfolio holdings
AUM
$59.7B
1-Year Est. Return
29.08%
This Fund
S&P 500
This Quarter
Est. Return
-1.62%
1 Year Est. Return
+29.08%
3 Year Est. Return
+84.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$57.7B
AUM Growth
-$4.7B
(-7.5%)
Cap. Flow
-$2.64B
Cap. Flow
% of AUM
-4.58%
Top 10 Holdings %
Top 10 Hldgs %
12.87%
Holding
1,846
New
100
Increased
703
Reduced
859
Closed
118
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
D.R. Horton
DHI
|
+$230M |
| 2 |
APLU
Allspring Core Plus ETF
APLU
|
+$176M |
| 3 |
AINP
Allspring Income Plus ETF
AINP
|
+$158M |
| 4 |
AFIX
Allspring Broad Market Core Bond ETF
AFIX
|
+$145M |
| 5 |
CSX Corp
CSX
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBRE Group
CBRE
|
+$261M |
| 2 |
NVIDIA
NVDA
|
+$260M |
| 3 |
Salesforce
CRM
|
+$231M |
| 4 |
Allstate
ALL
|
+$200M |
| 5 |
TSMC
TSM
|
+$147M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.54% |
| 2 | Industrials | 14.63% |
| 3 | Financials | 13.82% |
| 4 | Consumer Discretionary | 10.47% |
| 5 | Healthcare | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Eastern Bankshares
EBC
$5.34B
| $277K | ﹤0.01% |
+16,840
| New | +$293K |
|
1602
Freshworks
FRSH
$3.22B
| $276K | ﹤0.01% |
19,566
+6,862
| +54% | +$115K |
|
1603
Urban Edge Properties
UE
$2.75B
| $274K | ﹤0.01% |
14,414
+222
| +2% | +$4.44K |
|
1604
Prudential
PUK
$34.2B
| $272K | ﹤0.01% |
+12,535
| New | +$224K |
|
1605
Jakks Pacific
JAKK
$288M
| $271K | ﹤0.01% |
+10,937
| New | +$309K |
|
|
OPRA
1606
Opera Ltd
OPRA
$1.78B
| $271K | ﹤0.01% |
17,000
+3,300
| +24% | +$61.1K |
|
|
MRC
1607
DELISTED
MRC Global
MRC
| $270K | ﹤0.01% |
23,234
+8,034
| +53% | +$104K |
|
1608
National Health Investors
NHI
$3.47B
| $268K | ﹤0.01% |
3,635
+495
| +16% | +$34.9K |
|
1609
Par Pacific Holdings
PARR
$3.9B
| $265K | ﹤0.01% |
18,601
+6,522
| +54% | +$102K |
|
1610
Franklin Resources
BEN
$17.1B
| $264K | ﹤0.01% |
13,662
-805
| -6% | -$16.1K |
|
1611
First Busey Corp
BUSE
$2.58B
| $263K | ﹤0.01% |
+12,213
| New | +$284K |
|
1612
Asbury Automotive
ABG
$3.76B
| $262K | ﹤0.01% |
+1,164
| New | +$304K |
|
1613
Reliance Steel & Aluminium
RS
$21.8B
| $262K | ﹤0.01% |
907
-289
| -24% | -$82.7K |
|
1614
Caesars Entertainment
CZR
$6.04B
| $261K | ﹤0.01% |
10,495
+1,360
| +15% | +$44.2K |
|
1615
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.2B
| $258K | ﹤0.01% |
3,076
-5,327
| -63% | -$480K |
|
1616
Hercules Capital
HTGC
$3.11B
| $252K | ﹤0.01% |
13,100
| – | – |
|
1617
BridgeBio Pharma
BBIO
$16.4B
| $251K | ﹤0.01% |
+7,610
| New | +$257K |
|
1618
JD.com
JD
$42.7B
| $251K | ﹤0.01% |
+6,065
| New | +$243K |
|
1619
Pioneer Bancorp
PBFS
$419M
| $251K | ﹤0.01% |
21,395
+770
| +4% | +$8.96K |
|
1620
Vanguard Morningstar Value ETF
VTV
$193B
| $246K | ﹤0.01% |
1,426
+1,142
| +402% | +$199K |
|
1621
Collegium Pharmaceutical
COLL
$834M
| $244K | ﹤0.01% |
+8,180
| New | +$250K |
|
1622
Janux Therapeutics
JANX
$1.02B
| $244K | ﹤0.01% |
9,033
+3,168
| +54% | +$119K |
|
1623
Southern California Bancorp
BCAL
$701M
| $244K | ﹤0.01% |
16,998
+1,045
| +7% | +$16.2K |
|
1624
Universal Display
OLED
$4.23B
| $242K | ﹤0.01% |
+1,744
| New | +$261K |
|
1625
Costamare
CMRE
$1.71B
| $242K | ﹤0.01% |
24,567
+9,327
| +61% | +$103K |
|
Similar funds
QCM
NAMI
Allspring Global Investments's Q1 2025 Portfolio in Review
As of Q1 2025, Allspring Global Investments held 1,846 positions worth $57.7B, down 7.5% from $62.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Allspring Global Investments withdrew a net $2.64B in Q1 2025, closing 118 positions and reducing 859 holdings. Its most notable exit was Huntsman Corp, an estimated $116M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 22% a quarter earlier, followed by Industrials and Financials.
Against the trend, Allspring Global Investments opened a new position in Alnylam Pharmaceuticals worth $69.3M.
- Allspring Global Investments's largest Q1 2025 buy was Alnylam Pharmaceuticals: 270,924 shares worth $69.3M.
- Allspring Global Investments added most to D.R. Horton in Q1 2025, an estimated $230M increase.
- Allspring Global Investments's biggest Q1 2025 reduction was CBRE Group, cutting an estimated $261M.
- Allspring Global Investments fully exited Huntsman Corp in Q1 2025, selling an estimated $116M.
- Allspring Global Investments's ten largest holdings make up 13% of its $57.7B portfolio in Q1 2025.
- Allspring Global Investments opened 100 new positions and closed 118 in Q1 2025.
- Allspring Global Investments's portfolio value fell 7.5% quarter-over-quarter to $57.7B.
Based on Allspring Global Investments's 13F filing for Q1 2025, filed 24 Apr 2025.